Vincerx Pharma Inc [NASDAQ: VINC] slipped around -0.02 points on Friday, while shares priced at $0.68 at the close of the session, down -2.81%.
Compared to the average trading volume of 941.54K shares, VINC reached a trading volume of 225153 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Vincerx Pharma Inc [VINC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VINC shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VINC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Vincerx Pharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 14, 2022. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on December 23, 2021, representing the official price target for Vincerx Pharma Inc stock. Previously, the target price had yet another raise to $24, while SVB Leerink analysts kept a Outperform rating on VINC stock.
How has VINC stock performed recently?
Vincerx Pharma Inc [VINC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.98. With this latest performance, VINC shares dropped by -23.74% in over the last four-week period, additionally sinking by -1.62% over the last 6 months – not to mention a drop of -60.24% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VINC stock in for the last two-week period is set at 31.65, with the RSI for the last a single of trading hit 28.26, and the three-weeks RSI is set at 35.62 for Vincerx Pharma Inc [VINC]. The present Moving Average for the last 50 days of trading for this stock 2.3767, while it was recorded at 0.6979 for the last single week of trading, and 1.6953 for the last 200 days.
Vincerx Pharma Inc [VINC]: Deeper insight into the fundamentals
Vincerx Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.72 and a Current Ratio set at 0.72.
Insider trade positions for Vincerx Pharma Inc [VINC]
The top three institutional holders of VINC stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in VINC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in VINC stock with ownership which is approximately 5.8386%.
